Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss

Journal of Bone and Mineral Research

Volumn 27, Issue 12, 2012, Pages 2442-2451

  Kleyer, Arnd ^a,b   Scholtysek, Carina ^a,b   Bottesch, Edith ^a,b   Hillienhof, Ulrike ^c   Beyer, Christian ^a   Distler, Jörg Hw ^a   Tuckermann, Jan P ^c   Schett, Georg ^a   Krönke, Gerhard ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

LIVER X RECEPTORS; NUCLEAR RECEPTORS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS

Indexed keywords

LIVER X RECEPTOR; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE TURNOVER; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOPOROSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PROTECTION; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; BENZOATES; BENZYLAMINES; BONE RESORPTION; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; HUMANS; MICE; ORPHAN NUCLEAR RECEPTORS; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS; OSTEOPROTEGERIN; OVARIECTOMY; RANK LIGAND;

EID: 84869454050     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1702     Document Type: Article

References (23)

1. Nakahama K., Cellular communications in bone homeostasis and repair. Cell Mol Life Sci. 2010 Dec; 67 (23): 4001-9.
2. Rachner TD, Khosla S, Hofbauer LC., Osteoporosis: now and the future. Lancet. 2011 Apr 9; 377 (9773): 1276-87.
3. Wilson C., Osteocytes, RANKL and bone loss. Nat Rev Endocrinol. 2011 Dec; 7 (12): 693.
4. Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H., Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med. 2011 Oct; 17 (10): 1231-4.
5. Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O'Brien CA., Matrix-embedded cells control osteoclast formation. Nat Med. 2011 Oct; 17 (10): 1235-41.
6. Frenkel B, Hong A, Baniwal SK, Coetzee GA, Ohlsson C, Khalid O, Gabet Y., Regulation of adult bone turnover by sex steroids. J Cell Physiol. 2010 Aug; 224 (2): 305-10.
7. Walsh NC, Gravallese EM., Bone remodeling in rheumatic disease: a question of balance. Immunol Rev. 2010 Jan; 233 (1): 301-12.
8. Eriksen EF., Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord. 2010 Dec; 11 (4): 219-27.
9. Bensinger SJ, Tontonoz P., Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 2008 Jul 24; 454 (7203): 470-7.
10. Zelcer N, Tontonoz P., Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest. 2006 Mar; 116 (3): 607-14.
11. Robertson KM, Norgard M, Windahl SH, Hultenby K, Ohlsson C, Andersson G, Gustafsson JA., Cholesterol-sensing receptors, liver X receptor alpha and beta, have novel and distinct roles in osteoclast differentiation and activation. J Bone Miner Res. 2006 Aug; 21 (8): 1276-87.
12. Prawitt J, Beil FT, Marshall RP, Bartelt A, Ruether W, Heeren J, Amling M, Staels B, Niemeier A., Short-term activation of liver X receptors inhibits osteoblasts but long-term activation does not have an impact on murine bone in vivo. Bone. 2011 Feb; 48 (2): 339-46.
13. Remen KM, Henning P, Lerner UH, Gustafsson JA, Andersson G., Activation of liver X receptor (LXR) inhibits receptor activator of nuclear factor kappaB ligand (RANKL)-induced osteoclast differentiation in an LXRbeta-dependent mechanism. J Biol Chem. 2011 Sep 23; 286 (38): 33084-94.
14. Wattler S, Kelly M, Nehls M., Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques. 1999 Jun; 26 (6): 1150-6. 8, 60.
15. O'Gorman S, Dagenais NA, Qian M, Marchuk Y., Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci U S A. 1997; 94: 14602-7.
16. Kronke G, Bochkov VN, Huber J, Gruber F, Bluml S, Furnkranz A, Kadl A, Binder BR, Leitinger N., Oxidized phospholipids induce expression of human heme oxygenase-1 involving activation of cAMP-responsive element-binding protein. J Biol Chem. 2003 Dec 19; 278 (51): 51006-14.
17. Hayer S, Steiner G, Gortz B, Reiter E, Tohidast-Akrad M, Amling M, Hoffmann O, Redlich K, Zwerina J, Skriner K, Hilberg F, Wagner EF, Smolen JS, Schett G., CD44 is a determinant of inflammatory bone loss. J Exp Med. 2005 Mar 21; 201 (6): 903-14.
18. Kronke G, Uderhardt S, Kim KA, Stock M, Scholtysek C, Zaiss MM, Surmann-Schmitt C, Luther J, Katzenbeisser J, David JP, Abdollahi-Roodsaz S, Tran K, Bright JM, Binnerts ME, Akhmetshina A, Bohm C, Distler JH, Joosten LA, Schett G, Abo A., R-spondin 1 protects against inflammatory bone damage during murine arthritis by modulating the Wnt pathway. Arthritis Rheum. 2010 Aug; 62 (8): 2303-12.
19. Raggatt LJ, Partridge NC., Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010 Aug 13; 285 (33): 25103-8.
20. Hayashi M, Nakashima T, Taniguchi M, Kodama T, Kumanogoh A, Takayanagi H., Osteoprotection by semaphorin 3A. Nature. 2012 May 3; 485 (7396): 69-74.
21. Venteclef N, Jakobsson T, Ehrlund A, Damdimopoulos A, Mikkonen L, Ellis E, Nilsson LM, Parini P, Janne OA, Gustafsson JA, Steffensen KR, Treuter E., GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev. 2010 Feb 15; 24 (4): 381-95.
22. Nieves JW, Cosman F., Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep. 2010 Mar; 8 (1): 34-9.
23. Kratzer A, Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D., Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia. J Lipid Res. 2009 Feb; 50 (2): 312-26.